Literature DB >> 6219905

Reduced sulfation of liver heparan sulfate in experimentally diabetic rats.

L Kjellén, D Bielefeld, M Hook.   

Abstract

Analyses by anion exchange chromatography indicate that heparan sulfate proteoglycans isolated from the livers of experimentally diabetic rats have a reduced net negative charge as compared with heparan sulfate proteoglycans from control rats. In contrast, the size of the normal and diabetic proteoglycans are indistinguishable as are the size of individual polysaccharide chains when compared by gel chromatography. The reduced net negative charge of heparin sulfate from diabetic rats is shown to be caused by a reduced number of sulfate groups present in the diabetic heparan sulfate. Results are presented suggesting that one of the biosynthetic enzymes; the N-deacelylase, which tentatively has been identified as a regulatory enzyme affecting the sulfate content of the polysaccharide chains, may be inhibited in the diabetic rat.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219905     DOI: 10.2337/diab.32.4.337

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  36 in total

1.  Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; H B Dijkman; J A van der Laak; J H Berden
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

Authors:  Jennifer M MacArthur; Joseph R Bishop; Kristin I Stanford; Lianchun Wang; André Bensadoun; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells.

Authors:  Sedegheh Gharagozlian; Jørgen Borrebaek; Tore Henriksen; Tone Kristin Omsland; Hamid Shegarfi; Svein Olav Kolset
Journal:  Eur J Nutr       Date:  2006-06-29       Impact factor: 5.614

4.  Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing.

Authors:  P Wang; J Keijer; A Bunschoten; F Bouwman; J Renes; E Mariman
Journal:  Diabetologia       Date:  2006-08-04       Impact factor: 10.122

5.  Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan.

Authors:  P Mahadevan; R G Larkins; J R Fraser; A J Fosang; M E Dunlop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 6.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

7.  Effect of bitter gourd and spent turmeric on constituents of glycosaminoglycans in different tissues in streptozotocin induced diabetic rats.

Authors:  G Suresh Kumar; B Vijayalakshmi; P V Salimath
Journal:  Mol Cell Biochem       Date:  2006-03-11       Impact factor: 3.396

8.  Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.

Authors:  Boris B Boyanovsky; Preetha Shridas; Michael Simons; Deneys R van der Westhuyzen; Nancy R Webb
Journal:  J Lipid Res       Date:  2008-12-03       Impact factor: 5.922

9.  Biosynthetic regulation of proteoglycans by aldohexoses and ATP.

Authors:  Y Kanwar; Y Yoshinaga; Z Liu; E Wallner; F Carone
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin.

Authors:  Juying Han; Fuming Zhang; Jin Xie; Robert J Linhardt; Linda M Hiebert
Journal:  Cardiovasc Diabetol       Date:  2009-08-20       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.